Evaluating the GCN5b bromodomain as a novel therapeutic target against the parasite Toxoplasma gondii is a research paper published in Experimental Parasitology (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI116496
National Institutes of Health
Grant: 5R01AI116496-02
The GCN5b acetylation complex in the AIDS pathogen Toxoplasma
National Institutes of Health
FWCI
2.29
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals